NCT06582290 Investigating the Clinical Utility of the Oxford Virtual Autism Assessment Tool (OVAAT)
| NCT ID | NCT06582290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oxford Health NHS Foundation Trust |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-09-22 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-09-22 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study is to evaluate a new Autism Spectrum Disorder (ASD) diagnostic tool (Oxford Virtual Autism Assessment Tool (OVAAT)) to see whether it can: * Be able to identify autistic traits * Be able to distinguish between autistic and non-autistic young people * Is the tool better, similar or worse than another evidence-based observational tool (ADOS-2) in identifying features of autism?
Eligibility Criteria
Inclusion Criteria: * Group 1: 13-18 year old young people waiting for an autism assessment in the Oxfordshire CAMHS Neurodevelopmental Conditions (NDC) pathway who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment. * Group 2: 13-18 year old young people with no neurodevelopmental or mental health conditions who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment. Exclusion Criteria: * Group 1: 13-18 year old young people waiting for an autism assessment in the Oxfordshire CAMHS NDC pathway who have an existing or suspected neurodevelopmental diagnosis other than autism (e.g. ADHD, Learning Disability) or significant mental health problem (e.g. major depression, psychosis, eating disorder) and/or who are unable to speak English fluently. * Group 2: 13-18 year olds with any suspected or current neurodevelopmental or mental health conditions and/or who are unable to speak English fluently.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06582290 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06582290 currently recruiting?
Yes, NCT06582290 is actively recruiting participants. Contact the research team at ovaat.study@oxfordhealth.nhs.uk for enrollment information.
Where is the NCT06582290 trial being conducted?
This trial is being conducted at Oxford, United Kingdom.
Who is sponsoring the NCT06582290 clinical trial?
NCT06582290 is sponsored by Oxford Health NHS Foundation Trust. The trial plans to enroll 60 participants.